Agoura Hills, CA, United States of America

Han Xu

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Han Xu

Introduction

Han Xu is a prominent inventor based in Agoura Hills, CA (US). He has made significant strides in the field of cancer treatment through his innovative research and development. With a total of 4 patents, his work focuses on enhancing immune cell therapies for various types of cancers.

Latest Patents

Han Xu's latest patents include groundbreaking compositions and methods for treating CEACAM positive cancers. This patent discloses immune cells that comprise a first activator receptor specific to CEA and a second inhibitory receptor. These innovations aim to improve the treatment of cancer by utilizing advanced immune cell technology. Another notable patent addresses HER2 positive cancers, detailing immune cells that feature a dual receptor system responsive to loss of heterozygosity in target cells. This invention includes an activator receptor specific to a HER2 antigen and an inhibitory receptor that targets antigens lost in cancer cells, thereby enhancing the efficacy of immune responses.

Career Highlights

Han Xu is currently associated with A2 Biotherapeutics, Inc., where he continues to push the boundaries of cancer research. His work is characterized by a commitment to developing novel therapeutic strategies that leverage the body's immune system to combat cancer effectively.

Collaborations

Some of Han Xu's notable coworkers include Carl Alexander Kamb and Julyun Oh. Their collaborative efforts contribute to the advancement of innovative cancer therapies.

Conclusion

Han Xu's contributions to cancer treatment through his patents and research are invaluable. His work exemplifies the potential of innovative therapies in the fight against cancer, showcasing the importance of continued research and development in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…